Navigation Links
1 scan per patient is not always enough
Date:10/19/2009

Reston, Va.Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatmenta limitation that the groups believe is contrary to good clinical practice under certain circumstances.

"It is absolutely critical for CMS to reconsider this decision," said Michael M. Graham, Ph.D., M.D., president of SNM and director of nuclear medicine at the University of Iowa Carver College of Medicine in Iowa City. "It is unacceptable to have reimbursement for only one scan when you need two in order to assess efficacy of treatment."

The letterwhich was signed by the leadership of the National Oncologic PET Registry (NOPR) Working Group, the Academy of Molecular Imaging, the American College of Nuclear Medicine, the American College of Radiology, the American Society for Radiation Oncology, the Institute for Molecular Technologies and SNMpresents CMS with three practical scenarios in which a second initial FDG-PET scan would be necessary for optimal patient care. The first example is when PET is used for the diagnosis or staging of a tumor and the course of treatment is determined to be radiation therapy. In certain circumstances, a second PET scan may be needed for successful radiation therapy planning.

Second, in the event that PET used to evaluate a suspicious lesion came back with false-negative results and the patient is later diagnosed with cancer, a second PET scan is needed for initial staging before treatment. Finally, the third scenario applies to patients with newly diagnosed cancer who had to delay their treatment either because of reluctance on their own part or because of another medical illness that needed to be addressed first. It may be medically necessary for that patient to undergo another PET scan to evaluate the disease after that prolonged period of time.

By presenting CMS with new supporting bodies of evidencesuch as studies that were not yet available during the original consideration periodthe groups are hoping that CMS will open the decision for reconsideration and extend coverage to two FDG-PET scans for those certain clinical scenarios. If CMS decides to reconsider this issue, it will have to go through the standard regulatory review process, and a final decision may not be made for more than 90 days.

The groups that submitted the letter comprise clinicians, academicians, researchers and nuclear medicine providers who use molecular imaging technologies. They have been working closely with CMS over the past several years to increase beneficiary access to PET/CT though the development of NOPR.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Nations RNs Hail Sen. Frankens Support for Safe Patient Handling Measure
2. Mayo Clinic clinicians develop new decision aid tool to help type 2 diabetes patients
3. Reconstructive Plastic Surgery Patients Honored for Giving Back
4. Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients
5. Center for Patient Insights Web Site Goes Live
6. New data showed type 2 diabetes patients experienced greater blood sugar reductions
7. Lahey Clinic selects Allen Technologies' Vigo Interactive Patient Care System
8. Dialysis Drawbacks Outweigh Benefits for Some Older Patients
9. Gentle touch may aid multiple sclerosis patients
10. Restoring the Physician/Patient Relationship: An Interview with Jackson Healthcare's CEO
11. Leading Southern California Physicians Report Patient Fears About Complexities of Flu Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
Breaking Medicine Technology: